Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The update shows minor UI/formatting adjustments and section reorganization without changes to the study's key details.
    Difference
    0.4%
    Check dated 2025-11-03T01:18:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    No significant changes detected. The page appears unchanged.
    Difference
    0.3%
    Check dated 2025-10-19T16:30:19.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 with new content entry (Bone osteosarcoma) and a government-funding operating-status notice; previous version note (v3.1.0) removed.
    Difference
    3%
    Check dated 2025-10-05T10:23:16.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Core content expanded with new medical topics and a version upgrade to v3.1.0; previous version tag v3.0.2 removed. Added codes likely identifiers for the new entries.
    Difference
    0.7%
    Check dated 2025-09-28T03:19:14.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.3%
    Check dated 2025-09-20T22:16:45.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed.
    Difference
    0.5%
    Check dated 2025-09-13T17:44:53.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.